Announcing Zuber Lawler as a Sponsor of ARDD 2025

Empowering the future of aging research: Zuber Lawler to sponsor ARDD 2025, the world's largest conference on aging research in the biopharmaceutical industry

2025-07-30

(Press-News.org) The University of Copenhagen is excited to announce Zuber Lawler as a Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.

“Zuber Lawler demonstrates meticulous attention to detail with a client-first mentality… They offer personalized care from highly intelligent and creative counsel… They have attorneys for pretty much any situation the client finds themselves in.” — Chambers USA 2025

Zuber Lawler is proud to be a sponsor for the 12th Aging Research & Drug Discovery Meeting. Recognized by Chambers USA, Legal 500, and Best Lawyers in America, Zuber Lawler is one of the most selective law firms in the United States, representing clients throughout the world from seven offices across the country. Zuber Lawler focuses on M&A, finance, real estate and other deals; intellectual property; antitrust, data/privacy, FDA, anti-corruption, and other regulatory work; employment; and litigation. In addition to representing Fortune companies as well as funds and government entities, Zuber Lawler represents leading companies in emerging industries and technologies. Zuber Lawler’s attorneys work in languages covering 90% of the world’s population.

Zuber Lawler Managing Partner Tom Zuber will moderate the Investor Panel on 27th of August 20:20-21:20 (CET). Mr. Zuber, recognized by Chambers USA, personally manages relationships with some 10 of the firm’s Fortune 1000 clients, including within the healthcare industry, as well as funds and government entities. He is a leading voice in relation to a variety of emerging industries and technologies, often focusing on longevity, legalized cannabis, and legalized psychedelics. He was named one of High Times “100 Most Influential People in the Cannabis Industry” on its most recent list, and sits on the board of the Psychedelics Medicine Coalition. He graduated summa cum laude in Biomedical Engineering from Rutgers University, before earning a master’s in public policy from Harvard University and a law degree from Columbia Law School.

ARDD has grown to become the largest and most important conference in longevity biotechnology. Each year, ARDD brings together a unique mix of academic luminaries, biotech innovators, investors, top pharmaceutical executives, physicians, and related health care professionals to discuss the latest advancements in aging research and the event provides unique opportunities to connect with brilliant minds, fostering collaboration and showcasing groundbreaking research in the field.

“We are extremely honored to host Professors Meldal and Levitt at ARDD2025. Their Nobel prize winning discoveries have been instrumental for drug development and molecular design in part through modelling of proteins and molecules, and in part through the ability to easily create new molecules. It is therefore a great pleasure that they are joining our conference.” said Morten Scheibye-Knudsen, MD, Ph.D., University of Copenhagen.

“We are really excited for ARDD2025, especially with Nobel Laureates Morten Meldal and Michael Levitt joining us. Their groundbreaking contributions have had a lasting impact on drug discovery, and having them at the conference is sure to make it an unforgettable experience.” said Daniela Bakula, Ph.D., University of Copenhagen.

“For 12 years, the Aging Research and Drug Discovery (ARDD) forum grew in size and in quality. It became the world’s main platform for academia-pharma-startup-investor partnership and dialogue. In 2025, the conference will feature the Nobel laureates, pharmaceutical industry executives and healthcare delivery leaders. ARDD is a unique platform for advancing longevity biotechnology around the world.” said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine.

“At ARDD we strive to highlight the cutting-edge research and clinical applications in a new discipline of healthy longevity medicine. Having Nobel laureates join and speak at the ARDD conference underscores the critical importance of grounding longevity science and medicine in evidence-based, scientifically rigorous approaches.” said Prof.Dr.Evelyne Bischof, the organizer of the Longevity Medicine Days.

Aging research has become a great platform for advancing drug discovery with blockbuster potential, with pharmaceutical leaders like Novartis, Biogen, and Eli Lilly actively supporting this transformative field. ARDD has established itself as the go-to venue where scientists and pharma companies collaborate, share insights, and launch aging-focused research initiatives. In 2024, industry leaders such as Eli Lilly, Novartis, Regeneron, Biogen, and Lundbeck presented their latest research at ARDD, highlighting the meeting's pivotal role in advancing healthspan and longevity science. Be part of ARDD 2025 and contribute to shaping the future of medicine.

For further information, images or interviews, please contact:

ardd@pharma.ai

About Aging Research for Drug Discovery Conference

At ARDD, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions. Furthermore, the meeting will include opinion leaders in AI to discuss the latest advances of this technology in the biopharmaceutical sector and how this can be applied to interventions. Notably, this year we will have a special day called Longevity Medicine Day, specifically for physicians where the leading-edge knowledge of clinical interventions for healthy longevity will be described. ARRD intends to bridge clinical, academic and commercial research and foster collaborations that will result in practical solutions to one of humanity's most challenging problems: aging. Our quest to extend the healthy lifespan of everyone on the planet.

END

ELSE PRESS RELEASES FROM THIS DATE:

Is this what 2,500-year-old honey looks like?

2025-07-30

Decades ago, archaeologists discovered a sticky substance in a copper jar in an ancient Greek shrine. And until recently, the identity of the residue was still murky — is it a mixture of fats, oils and beeswax or something else? Researchers publishing in the Journal of the American Chemical Society have reanalyzed samples of the residue using modern analytical techniques and determined that it’s likely the remains of ancient honey — a conclusion previous analyses rejected. Honey was an important substance in the ancient world, sometimes left in shrines as offerings ...

Economic evaluation of wastewater surveillance for COVID-19 testing in long-term care settings

2025-07-30

The COVID-19 pandemic has placed enormous pressure on healthcare systems and economies around the world, with particularly severe impacts on vulnerable groups like residents of long-term care facilities (LTCFs). One key lesson from the pandemic is that early detection and treatment can lower hospitalization and death rates while also cutting medical costs. Wastewater surveillance at treatment plants (WSTPs) has emerged as a low-cost and innovative method to detect outbreaks early. Many developed countries have adopted this approach, ...

Announcing Deep Origin as a sponsor of ARDD 2025

2025-07-30

The University of Copenhagen is excited to announce Deep Origin as the latest tier 3 sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online. Deep Origin is building hybrid mechanistic, physics and AI-based models that help researchers design, test, and filter therapeutics in silico – particularly for challenging disease areas such as aging. ...

Cancer cells ‘power up’ when literally pressed to the limit

2025-07-30

Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the journal Nature Communications. The surge of energy is the first reported instance of a defensive mechanism which helps the cells repair DNA damage and survive the crowded environments of the human body. The findings help explain how cancer cells survive complex mechanical gauntlets like crawling through a tumour microenvironment, sliding into porous blood vessels or enduring the battering of the bloodstream. The discovery of the ...

Huge hidden flood bursts through the Greenland ice sheet surface

2025-07-30

A huge flood triggered by the rapid draining of a lake beneath the Greenland ice sheet occurred with such force that it fractured the ice above and burst out across its surface. This phenomenon, observed for the first time in Greenland and detailed in research published today in the journal Nature Geoscience, sheds new light on the destructive potential of meltwater stored beneath the ice sheet. It reveals how, under extreme conditions, water flooding underneath the ice can force its way upwards through the ice and escape at the ice sheet surface. This phenomenon is not considered by numerical models ...

The brain shapes what we feel in real time

2025-07-30

The cerebral cortex processes sensory information via a complex network of neural connections. How are these signals modulated to refine perception? A team from the University of Geneva (UNIGE) has identified a mechanism by which certain thalamic projections target neurons and modify their excitability. This work, published in Nature Communications, reveals a previously unknown form of communication between two regions of the brain, the thalamus and the somatosensory cortex. It could explain why the same sensory stimulus does not always elicit the same sensation ...

New study confirms post-pandemic surge in gut-brain disorders

2025-07-30

Bethesda, MD (July 29, 2025) — A new international study confirmed a significant post-pandemic rise in disorders of gut-brain interaction, including irritable bowel syndrome (IBS) and functional dyspepsia, according to the paper published in Clinical Gastroenterology and Hepatology. Building on prior research, investigators used Rome Foundation diagnostic tools to analyze nationally representative samples from both 2017 and 2023 — offering the first direct, population-level comparison of disorders of gut-brain interaction prevalence before and after the COVID-19 pandemic. Key findings: Overall disorders of gut-brain ...

Through the shot glass, and what can be found in liverworts

2025-07-30

Studying plant vegetative reproduction is key to increasing crop yield and for bioengineering. Kobe University research is making progress on studying the genetic regulation of the process in liverworts, which are ideal model plants and even a candidate for space crops. Potatoes are tubers, ginger is a rhizome, and both are forms of vegetative plant reproduction, in which plants create structures from which genetically identical individuals can emerge. This mode of reproduction is very important for agriculture and horticulture, but there is very little research on the underlying genetic mechanism. Kobe University ...

Stepping for digital rewards

2025-07-30

Walking is well known to have significant health benefits, but few people achieve the daily recommended steps. Fortunately, mobile health (mHealth) applications have emerged as promising tools to promote physical activity. These apps track user activities on mobile devices to deliver health and wellness services. However, the effectiveness of these apps in increasing daily walking behavior remains underexplored, partly due to variations in their incentive structures. Dr. Haruka Kato, Junior Associate Professor at Osaka Metropolitan University, investigated the impact of incentive design on walking behavior using a local mHealth application called ...

Developing next-generation analytical technique for gene and cell doping and ensuring ethics and fairness in sports

2025-07-30

Changmin Sung, a principal researcher at the Doping Control Center at the Korea Institute of Science and Technology (KIST), announced that he and his collaborators at the Department of Biomedical Engineering at Korea University have developed a high-throughput multiplexed gene and cell doping analysis (HiMDA) based on gene scissors (CRISPR-Cas). Unethical doping practices to enhance athletic performance is becoming more sophisticated with the use of advanced technology, and gene and cell doping - the ...

Announcing Zuber Lawler as a Sponsor of ARDD 2025

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: